SCHEMBL15216702

SCHEMBL15216702

N#Cc1cncc(-c2ccnc3cc(-c4ccc(OCCO)cc4)oc23)c1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 2/20 0.36
P4HTM Q9NXG6 1/20 0.36
ABL1 P00519 8/20 0.35
CYP11B1 P15538 3/20 0.35
CYP11B2 P19099 3/20 0.35
MAP4K4 O95819 1/20 0.34
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
CDC42BPB Q9Y5S2 1/20 0.33
PRKAB2 O43741 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA2 P54646 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAG3 Q9UGI9 1/20 0.33
PRKAG2 Q9UGJ0 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33
TBXAS1 P24557 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15216713 0.88 USP7 (0.36) USP7P4HTMCYP11B1CYP11B2MAP4K4
SCHEMBL722186 0.86 CHEK1 (0.36) MAP4K4PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL722901 0.86 HRH3 (0.44)
SCHEMBL721951 0.85 CYP2D6 (0.34) ABL1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL15216701 0.85 P4HTM (0.35) USP7P4HTMABL1CYP11B1CYP11B2
SCHEMBL722171 0.84 CYP3A4 (0.45) CYP11B1CYP11B2
SCHEMBL723926 0.83 CA12 (0.34) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL725081 0.82 IRAK4 (0.37) USP7P4HTMABL1MAP4K4ROCK2
SCHEMBL15216703 0.81 PIK3C3 (0.38)
SCHEMBL723867 0.80 PRKAB2 (0.36) MAP4K4PRKAB2PRKAG1PRKAA2PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB USP7 3320/4885P4HTM 2912/4885ABL1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.